{"id":"https://openalex.org/W2413957904","doi":null,"title":"Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.","display_name":"Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2413957904","mag":"2413957904","pmid":"https://pubmed.ncbi.nlm.nih.gov/14668700"},"language":"en","primary_location":{"id":"pmid:14668700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14668700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reviews in cardiovascular medicine","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109231574","display_name":"STUART W. ZARICH","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stuart W Zarich","raw_affiliation_strings":["Yale University School of Medicine, New Haven, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Medicine, New Haven, Connecticut, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109231574"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":0.9545,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.75791221,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"4 Suppl 6","issue":null,"first_page":"S19","last_page":"28"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6929000020027161,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6929000020027161,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.2896000146865845,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.7360000014305115},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9259999990463257},{"id":"https://openalex.org/keywords/small-dense-ldl","display_name":"small dense LDL","score":0.8529999852180481},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7680000066757202},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.6169999837875366},{"id":"https://openalex.org/keywords/impaired-glucose-tolerance","display_name":"impaired glucose tolerance","score":0.8650000095367432},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.8809999823570251},{"id":"https://openalex.org/keywords/lifestyle-modification","display_name":"lifestyle modification","score":0.9679999947547913},{"id":"https://openalex.org/keywords/diet","display_name":"diet","score":0.4749999940395355},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.996999979019165},{"id":"https://openalex.org/keywords/exercise","display_name":"physical activity","score":0.9810000061988831},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.8730000257492065},{"id":"https://openalex.org/keywords/macrovascular-complications","display_name":"macrovascular complications","score":0.9490000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9555944204330444},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.8040586113929749},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7277313470840454},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.7260522246360779},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.653287410736084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5951325297355652},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.527144193649292},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5103639960289001},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49079570174217224},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4869345426559448},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32697033882141113},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006943","descriptor_name":"Hyperglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:14668700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14668700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reviews in cardiovascular medicine","raw_type":"Journal Article"},{"id":"mag:2413957904","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14668700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W74574975","https://openalex.org/W303812557","https://openalex.org/W1485696359","https://openalex.org/W1502524639","https://openalex.org/W1969927159","https://openalex.org/W1974947331","https://openalex.org/W1977386411","https://openalex.org/W2001680929","https://openalex.org/W2007731253","https://openalex.org/W2014877159","https://openalex.org/W2023097850","https://openalex.org/W2027702390","https://openalex.org/W2044773944","https://openalex.org/W2045658220","https://openalex.org/W2046503553","https://openalex.org/W2059537042","https://openalex.org/W2063468187","https://openalex.org/W2069150029","https://openalex.org/W2082162145","https://openalex.org/W2083342497","https://openalex.org/W2087366614","https://openalex.org/W2090895117","https://openalex.org/W2097288698","https://openalex.org/W2102772338","https://openalex.org/W2102979143","https://openalex.org/W2105813749","https://openalex.org/W2117092539","https://openalex.org/W2118267307","https://openalex.org/W2132594773","https://openalex.org/W2133217116","https://openalex.org/W2137408480","https://openalex.org/W2138119952","https://openalex.org/W2139634859","https://openalex.org/W2140396611","https://openalex.org/W2143600334","https://openalex.org/W2148715056","https://openalex.org/W2154909966","https://openalex.org/W2156121263","https://openalex.org/W2158822657","https://openalex.org/W2160452475","https://openalex.org/W2166213644","https://openalex.org/W2166895394","https://openalex.org/W2312999996","https://openalex.org/W2322095705","https://openalex.org/W2330542318","https://openalex.org/W2331274940","https://openalex.org/W2332951586","https://openalex.org/W2752336761","https://openalex.org/W4231265939"],"related_works":["https://openalex.org/W4200036905","https://openalex.org/W1994396153","https://openalex.org/W980899349","https://openalex.org/W2168933286","https://openalex.org/W2513062212","https://openalex.org/W2165991124","https://openalex.org/W2906536197","https://openalex.org/W2049859140","https://openalex.org/W2004576418","https://openalex.org/W2019955194"],"abstract_inverted_index":{"Diabetes,":[0],"a":[1,15,103,161],"leading":[2],"cause":[3],"of":[4,23,38,53,94,160],"morbidity":[5],"and":[6,43,71,130,139,155,168],"mortality":[7],"in":[8,20,30,49,106,146,171],"the":[9,21,28,31,36,50],"United":[10,32],"States,":[11],"is":[12,113],"associated":[13,101,115],"with":[14,65,79,102,116,173],"2-":[16],"to":[17,74,127,164],"4-fold":[18],"increase":[19,105],"risk":[22],"coronary":[24],"artery":[25],"disease.":[26,108],"As":[27],"population":[29],"States":[33],"has":[34,45],"aged,":[35],"incidence":[37],"obesity,":[39],"hypertension,":[40],"glucose":[41],"intolerance,":[42],"dyslipidemia":[44],"increased":[46,92,117],"significantly,":[47],"culminating":[48],"current":[51],"epidemic":[52],"type":[54,80,174],"2":[55,81,110,175],"diabetes":[56,82,111],"mellitus.":[57],"Strict":[58],"glycemic":[59,128,151],"control":[60,129],"must,":[61],"therefore,":[62],"be":[63],"accompanied":[64],"proven":[66],"therapies":[67],"(such":[68],"as":[69],"antihypertensives":[70],"lipid-lowering":[72],"agents)":[73],"reduce":[75],"cardiovascular":[76,107],"events.":[77],"Patients":[78],"have":[83,90],"average":[84],"low-density":[85],"lipoprotein":[86],"(LDL)":[87],"levels":[88],"but":[89],"an":[91,143],"number":[93],"small,":[95],"dense":[96],"LDL":[97],"particles,":[98,121],"which":[99,122],"are":[100,158],"3-fold":[104],"Type":[109],"mellitus":[112],"also":[114,141],"triglyceride":[118],"rich":[119],"atherogenic":[120],"trigger":[123],"inflammation.":[124],"In":[125],"addition":[126],"drug":[131],"therapy,":[132,154],"lifestyle":[133,156],"modifications":[134,157],"(eg,":[135],"diet,":[136],"weight":[137],"loss,":[138],"exercise)":[140],"play":[142],"important":[144],"role":[145],"managing":[147],"diabetes.":[148,176],"Therefore,":[149],"strict":[150],"control,":[152],"pharmacologic":[153],"parts":[159],"comprehensive":[162],"strategy":[163],"prevent":[165],"both":[166],"microvascular":[167],"macrovascular":[169],"events":[170],"patients":[172]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}